Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Nationals Rumors

Nationals Option Kyle Barraclough, Recall Adrian Sanchez

By | at

The Nationals optioned Kyle Barraclough to Double-A Harrisburg today, recalling well-traveled infielder Adrian Sanchez, the team announced.

Barraclough, 29, represents the “successful” half of the Nats offseason bullpen upgrades. Entering the season, Washington hoped to install the since-departed Trevor Rosenthal as their eighth inning man, with Barraclough targeted for seventh inning setup duties. Obviously, the Nats had to audible not long into the season as Rosenthal imploded like few pitchers can, while Barraclough’s struggles were more pedestrian in comparison. Still, Barraclough ultimately landed on the injured list with nerve irritation in mid-June.

Yesterday marked Barraclough’s return, which he celebrated with a wild pitch before Justin Turner launched a 3-1 get-me-over fastball into the left field bleachers for the  game-winning three-run homer. He did retire Cody Bellinger to end the inning, but Barraclough nonetheless finds himself headed back from whence he came not 24 hours after his arrival.

For the season, the Nats called on Barraclough 33 times for 25 2/3 innings with a 6.66 ERA (6.57 FIP). His walk rate (4.2 BB/9) is actually at a career low, while his 10.5 K/9 is his highest mark since 2016. Those improvements have paled in comparison to the regression in terms of quality of contact surrendered, however. Hitters against Barraclough have seen their year-over-year solid contact rates improve from 1.4% to 10.0% and barrel rates from 4.8% to 13.8%. Those contact rates have yielded 11.6 hits per nine innings and 2.8 HR/9.

As for Sanchez, 28, he returns to his place at the end of the Nationals bench. Today marks Sanchez’s seventh stint with the big league club this season, where he serves as the emergency backup shortstop and rarely-used 25th man. For the season he has started just once with 20 total plate appearances. He has four hits and seven strikeouts. Without Sanchez, the Nationals don’t have a backup for shortstop Trea Turner on the roster, but given the rarity with which the Nats put Sanchez to use, one would think a playoff contender like Washington could find a better use for a roster spot.

Max Scherzer Dealing With Renewed Upper Back Issues

By | at

After coming off of the injured list to start yesterday, Nationals ace Max Scherzer woke up with renewed stiffness in his back, Mark Zuckerman of MASNsports.com reports. It is not clear at this point whether he’ll skip his next scheduled start and/or require a return trip to the 10-day IL.

An MRI taken this morning revealed a mild rhomboid strain. That’s a different issue in the same area of the upper back/shoulder. Scherzer had previously been dealing with an inflamed bursa sac in the vicinity of his shoulder blade. To treat the new problem, Scherzer has undergone a stem-cell injection. His response to that will be assessed in a few days.

While the Nats need every single Scherzer outing they can get, the team is also walking a bit of a tightrope. Allowing the fiery veteran to push himself too hard could easily backfire. And Scherzer wasn’t quite at his best in his return start, though he was still effective and did emphasize that he felt at full health going into and during the outing.

The uncertainty surrounding Scherzer comes at an interesting time for the Nationals. There was already a case to be made that this team could use a starting pitcher. There’s all the more reason to do so now, if only to buy some time to give Scherzer ample rest.

One route would be to grab a fill-in rotation piece that can check down to a relief role. Derek Holland might’ve made sense in that capacity, particularly since the Nats could use a southpaw and he has been so nasty against opposing lefties. But the team didn’t jump on the opportunity, with Holland landing today with the Cubs. Similar hurlers could yet make sense. The tough thing for the D.C. organization will be to balance the imperative to buttress the rotation with a still-glaring need for multiple, quality relief arms.

Latest On Nationals’ Bullpen Pursuits

By | at

4:10pm: The Nats are also in touch with the Blue Jays regarding their relief arms, per Jon Morosi of MLB Network (via Twitter). Both Ken Giles and Daniel Hudson are said to be of interest to D.C.

11:40am: The Nationals are known to be on the lookout for multiple relievers following their meteoric rise back up the standings, and ESPN’s Buster Olney writes that the team’s preference is to add a left-handed reliever. General manager Mike Rizzo won’t limit himself to only southpaws, though, and to that end, MLB.com’s Jon Morosi tweets that the Nationals are in active pursuit of White Sox righty Alex Colome and Tigers righty Shane Greene.

Washington’s interest in Greene isn’t new; it’s been reported on multiple times in the past and is also a relatively obvious match simply from a common sense standpoint. The Nationals figure to have checked in on virtually every reliever’s asking price by now, and MLB.com’s Jamal Collier recently reported that the Tigers made the sky-high ask of top shortstop prospect Carter Kieboom in initial talks with the Nationals. One can hardly blame the Tigers for aiming high, but that price point indeed seems rather lofty. Still, the fact that Washington is still showing interest suggests that the two sides could come to terms on a deal just yet.

Whether the White Sox were keen on moving Colome earlier this month wasn’t clear, but the South Siders’ poor play of late has dropped them to 10 games under .500. The club is making efforts to move beyond its rebuild and plans to make a push in 2020, so perhaps the preference is to retain Colome. Still, he’ll likely top $10MM in arbitration earnings next season, so it’d also be reasonable for Chicago to cash in if GM Rick Hahn can find a trade partner willing to make a decent offer.

Both Greene and Colome are controlled through the 2020 season, with Greene’s $4MM salary checking in considerably lower than Colome’s $7.325MM rate. As such, even though Greene is having a better season, his salary next year will likely be more affordable.

In 37 innings, Greene has posted a pristine 1.22 ERA with 10.0 K/9, 2.7 BB/9, 1.22 HR/9 and a 54.3 percent ground-ball rate. Colome, meanwhile, has a rather pedestrian 7.0 K/9 mark against 2.8 BB/9 and 0.93 HR/9. Both closers have benefited tremendously from unsustainable averages on balls in play (.180 for Greene and .153 for Colome) and strand rates near 83 percent. Greene’s lower salary and superior strikeout and ground-ball rates make him to more appealing of the pair but also mean that he’ll probably come with a higher asking price. And even with some degree of regression likely for both pitchers, each is still a quality arm who’d give the Nats a much-needed upgrade to a setup corps that has been problematic all season long.

Royals Working On Jake Diekman Trade

By | at

12:02pm: The Dodgers stood out as the likely “frontrunners” from the start, tweets Jeffrey Flanagan of MLB.com. However, he adds that the Nationals and Phillies both still have Diekman on their radar.

11:53am: The Royals “could be getting closer” to a trade involving left-handed reliever Jake Diekman, tweets Mark Feinsand of MLB.com. Both the Braves and Dodgers have been showing strong interest in the southpaw, he adds.

Diekman, 32, is playing out the season on a one-year, $2.25MM contract, though he’s also owed a $500K buyout on a $5.75MM mutual option that doesn’t seem likely to be exercised (as is the case with virtually all mutual options). That puts the remaining obligation to Diekman around $1.3MM between now and season’s end.

While Diekman’s 4.75 ERA isn’t going to excite most fans, he’s also notched a hefty 13.6 K/9 mark and kept the ball on the ground at a 48-4 percent clip. Left-handed opponents have batted just .213 and slugged .255 against him. As has oft been the case for Diekman throughout his career, though, control has been an issue. He’s averaged five walks per nine innings pitched this season and plunked another eight hitters. As such, Diekman has yielded an overall .213/.362/.255 line to lefties and a .211/.331/.358 line to right-handed hitters.

Diekman is technically controlled beyond the 2019 season, but mutual options are almost never exercised by both parties. Typically, if a player performs well enough to justify that salary, he’s inclined to test the open market. And if a player doesn’t perform up to that standard, the club will of course buy the option out. Perhaps the changing landscape of free agency will make a player such as Diekman — one with limited earning power but who could justify a net $5.25MM decision with a strong finish — more likely to exercise his half of the provision, but there’s limited historic precedent.

Nationals Activate Max Scherzer

By | at

The Nationals announced Thursday that they’ve activated ace Max Scherzer from the injured list. Catcher Raudy Read was optioned to Triple-A to open a spot on the active roster.

Scherzer hasn’t taken the mound since July 6 due to a mid-back strain. His return will be a boost for an already-surging Nationals club that has flipped the script after an awful April/May showing raised questions about the team perhaps operating as a seller. The Nats needed a dramatic turnaround, and they managed to author exactly that, as they’ve played at an outstanding 30-13 pace dating back to June 1. Washington now finds itself just four games back of the Braves in the NL East and in possession of an NL Wild Card spot.

Getting a healthy Scherzer only strengthens a powerhouse roster. The three-time Cy Young winner, who’ll turn 35 in two days, is putting together one of the best seasons of his career. Through 129 1/3 innings, Mad Max has posted a 2.30 ERA with 12.6 K/9 against 1.6 BB/9. Even though he hasn’t pitched in nearly three weeks, he’s still leading the National League with 181 strikeouts — a total that ranks fourth in all of baseball (behind Gerrit Cole, Justin Verlander and Chris Sale).

Scherzer’s return isn’t the only news pertaining to the Nats’ pitching staff today, however. An MRI of right-hander Austin Voth’s ailing shoulder revealed tendinitis, manager Dave Martinez announced to reporters (Twitter link via Mark Zuckerman of MASNsports.com). He’s been shut down for the time being, and Martinez specified that the club will be “very careful” with the righty. Voth has made four starts and posted a 4.35 ERA through 20 2/3 innings with the Nats in 2019. He also has a 4.40 ERA and nearly 10 punchouts per nine innings pitched through 61 1/3 Triple-A frames, making him a key depth piece for the Nationals.

Max Scherzer Nearing Return

By | at

The Nationals are expecting ace Max Scherzer to return from the injured list by Thursday or Friday, Byron Kerr of MASNsports.com reports. Scherzer, out since July 13 with right shoulder bursitis, threw a full bullpen session Monday and offered an encouraging assessment afterward, per Kerr. The Nationals have maintained a playoff spot during Scherzer’s absence, but the three-time Cy Young winner is their MVP and someone they likely can’t go without for much longer. The 34-year-old Scherzer was amid another all-world season before hit hit the shelf, with a 2.30 ERA/2.02 FIP, 12.6 K/9, 1.6 BB/9 and 5.5 WAR in 129 1/3 innings.

Nationals Place Ryan Zimmerman On 10-Day IL, Select Michael Blazek

By | at

The Nationals have placed first baseman Ryan Zimmerman on the 10-day injured list. He’s dealing with an ongoing bout of plantar fasciitis.

As anticipated, the D.C. organization has also selected the contract of righty Michael Blazek. To create a 40-man opening, reliever Justin Miller was shifted to the 60-day injured list.

In other roster tweaks, the Nats have recalled outfielder Andrew Stevenson. To open the additional active roster spot, right-hander Kyle McGowin was optioned down.

Zimmerman already missed a lengthy stretch owing to the nagging foot issue. The 34-year-old has endured a rough campaign when he has been available, though he had been on a nice run this month. It seems Zimmerman will look to let the flare-up die down and return to action once he’s able to tolerate the pain, as Britt Ghiroli of The Athletic tweets. It stands to reason that Matt Adams will pick up the bulk of the playing time while Zimmerman is down, with Howie Kendrick likely stepping in against lefties.

As for Blazek, he’s now formally back in the bigs for the first time since 2017. He has a solid 28:10 K/BB ratio in 26 Triple-A innings, but has also coughed up 16 earned runs in that span. With the Nats continuing to search far and wide for passable relief pitching, they’ll give the 30-year-old a shot to get his career back on track. Blazek owns a 4.39 ERA through 123 career MLB innings.

Latest On Max Scherzer

By | at

TODAY:  Nationals GM Mike Rizzo told reporters (including Jesse Dougherty of the Washington Post) that he is “reasonably confident” Scherzer will come off the injured list this week.  As Dougherty notes, this projection carries some extra weight coming from Rizzo, who “is usually resistant to putting even loose timelines on injuries.”

FRIDAY: The Nats’ mid-season revival has been driven by exceptional starting pitching — particularly from the ever-dependable Max Scherzer. His unholy tear through the rest of the league was halted only by an unfortunate back issue that has cropped up, forcing a recent injured-list placement.

Scherzer provided an update today to reporters including Mark Zuckerman of MASNsports.com (via Twitter). What had been believed to be a mid-back strain is in fact an inflamed bursa sac in his back/shoulder area (formally, “scapulothoracic bursitis”). He’s throwing off flat ground while waiting for a cortisone shot to take effect.

It’s clear at this point that Scherzer will not pitch before the weekend is out. But he suggests that he ought to be ready to go in relatively short order thereafter. It’ll all depend upon the efficacy and speed of the treatment. Much as the Nats would love to have him back on the bump right away, they’ll need to be cautious of avoiding a larger problem.

It’s more or less impossible to overstate just how good Scherzer has been of late. Since the start of June, he has made seven starts, over which he has allowed just five earned runs on 29 hits in 52 innings. Scherzer has compiled an absurd 79:6 K/BB ratio in that span.

Even if he never threw another pitch in D.C., Scherzer’s blockbuster free agent contract would go down as a huge success. He has already thrown over one thousand innings of 2.65 ERA ball for the Nats, racking up over thirty wins above replacement in less than five full seasons. That he remains an outstanding pitcher with appealing (albeit not inexpensive) remaining guaranteed seasons is testimony to how unusually well that deal has turned out for the team.

As talented and driven as Scherzer is, no small portion of his value is connected to his ability to stay in good health. That has allowed him not only to fill up innings, but to do so at top speed. If the Nats are to chase down the Braves, or otherwise make noise in the postseason by entering through the Wild Card, they’ll need their ace in all his furious glory.

It goes without saying that Scherzer is irreplaceable. But the Nats may need to find another rotation piece over the next twelve days, particularly if there’s any concern that they may need to go a stretch without Scherzer. At present, Austin Voth and Erick Fedde account for the fifth rotation spot. Relying on those hurlers, with scant 40-man depth otherwise (Kyle McGowin, Joe Ross), would be dangerous. There’s no indication that Jeremy Hellickson is going to be an option at any point in the near future.

We already know the Nats will be looking for bullpen arms. But it’ll be interesting to see whether and how they approach the starting pitching market. Perhaps a swingman type would make sense as a partial hedge against a rotation need, without putting too many resources into a spot that may not need to be fully addressed.

Nationals Place Austin Voth On IL, Recall Joe Ross

By | at

The Nationals have placed right-handed pitcher Austin Voth on the 10-day injured list and have recalled pitcher Joe Ross, according to Jesse Dougherty of the Washington Post. Voth is dealing with bicep tendinitis; his IL placement comes retroactive to Thursday.

Voth, 27, has emerged as a capable starter for the Nationals, making four starts and posting a serviceable 4.35 ERA through 20 2/3 innings of work. He’s managed to strike out almost a batter per inning, accumulating 20 K’s compared to just 6 walks. He’ll hit a bump in the road with the injury, and the Nats will be down their fifth starter for at least ten days, but the good news is that Max Scherzer may be nearing a return to the rotation.

Ross, meanwhile, has spent the last month playing out an assignment in the minor leagues after a disappointing showing with the Big League team. Since being converted to a reliever, the 26-year-old has worked to a miserable 11.05 ERA in 17 outings, fueled in part by a walk rate that has ballooned to 11.5%, by far the worst mark of his career, which has spanned parts of five seasons. Those struggles earned him a demotion to Triple-A, where he has made eight starts and posted a 4.28 ERA.

Dougherty goes on to note (via Twitter) that relief pitcher Michael Blazek is expected to join the Nats’ active roster in the near future, and was considered to be added today. However, it looks as if the club intends to option Ross in the near future to make room for Blazek, who hasn’t appeared in a Major League game since 2017.

Max Scherzer Throws Bullpen Session

By | at

With summer storms peppering much of the country today, we’ve got our own torrent of pitcher-related news to sort through. Out of D.C., we hear from MLB.com’s Jamal Collier that Nationals ace Max Scherzer threw 15 pitches off of a mound this afternoon (Twitter link). The superlative hurler has been dealing with inflammation in the bursa sac under his right shoulder blade and hasn’t appeared in a game since a seven-inning win against the Royals on July 6th. That Scherzer is throwing again–and could possibly throw another bullpen on Monday–is a sign that he apparently took well to a recent cortisone shot in his ailing back. Given the notoriously fickle nature of back injuries, the Nats are likely to be over the moon at this positive step in Scherzer’s recovery.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top